Immunohistochemical analysis of cutaneous malignant melanoma: comparison of S–100 protein, HMB–45 monoclonal antibody and NKI/C3 monoclonal antibody
- 1 January 1994
- Vol. 26 (1) , 16-19
- https://doi.org/10.1080/00313029400169021
Abstract
Immunohistochemical analysis was carried out on 144 formalin fixed paraffin embedded cutaneous melanomas to ascertain the value of 3 different immune markers. The sensitivity and staining patterns regarding intensity and distribution, as well as correlation to pigment content, cell type, surface ulceration and host response was noted. The stains used were monoclonal HMB-45 (Dako product No M634), NKI/C3 antibodies (Biogenex product No MU077) and polyclonal rabbit anti S-100A protein (Dako product No L1845). Of the lesions tested, 63 were malignant melanoma with an adjacent component of superficial spreading type, 61 were malignant melanoma with no adjacent component, 2 were malignant melanoma with adjacent lentigo maligna, 8 were in situ with 7 superficial spreading melanoma and one lentigo maligna (HMF) and 10 were metastatic melanoma. All 144 lesions stained for S-100 (100% sensitivity). One hundred and thirty-seven stained for NKI/C3 (95%); 132 stained for HMB-45 (92% sensitivity). S-100 was the most sensitive marker and stained tumor cells diffusely. With HMB-45 and NKI/C3, though marginally less sensitive, staining was stronger and patchy. In addition, NKI/C3 showed a tendency for peripheral (membrane) staining. HMB-45 staining was directly proportional to the pigment content, with stronger staining of radial growth phase melanoma and negative staining of those lesions where pigment content was minimal or absent. Also, with HMB-45 a decrease in staining intensity with depth or vertical growth phase was observed. There was no relationship to cell type with HMB-45 but with NKI/C3, 5 out of the 7 that failed to stain showed spindle cell differentiation.(ABSTRACT TRUNCATED AT 250 WORDS)Keywords
This publication has 10 references indexed in Scilit:
- S‐100 protein: Is it useful as a tumour marker in diagnostic immunocytochemistry?Histopathology, 1989
- Comparison of HMB-45 Monoclonal Antibody and S-100 Protein in the Immunohistochemical Diagnosis of MelanomaAmerican Journal of Clinical Pathology, 1988
- Distribution of melanoma specific antibody (HMB-45) in benign and malignant melanocytic tumoursVirchows Archiv, 1988
- Correlation of histopathological characteristics with staining patterns in human melanoma assessed by (monoclonal) antibodies reactive on paraffin sectionsHistopathology, 1986
- A comparison of some methods for identifying amelanotic and oligomelanotic melanoma metastases in paraffin sectionsPathology, 1985
- Use of NK1 C3 monoclonal antibody in the assessment of benign and malignant melanocytic lesions.Journal of Clinical Pathology, 1984
- Role of Antibody to S100 Protein in Diagnostic PathologyAmerican Journal of Clinical Pathology, 1983
- Immunochemical and immunocytochemical study of S-100 protein in rat adipocytesBrain Research, 1983
- The value of S-100 immunostaining as a diagnostic tool in human malignant melanomasVirchows Archiv, 1983
- Immunohistochemical demonstration of S 100 protein in malignant melanoma and pigmented nevus, and its diagnostic applicationCancer, 1982